Trump’s prescription drug executive order rollback didn’t quash all Biden-backed cost savings
The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department secretary to consider "new health care payment and delivery models" for the Center for Medicare and Medicaid Innovation to test.
Hays and her husband who have a Medicare Part D drug plan. As a result, she expects to shell out a lot less at the pharmacy ...
Two bills heard in a state Senate committee are designed to lower prices, provide fair competition for independent pharmacies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback